Skip to main content

Mehrotra Parth's Form 4 filing

Privia Health Group, Inc. (PRVA) · filed Sep 21, 2022

Accession no.
0001759655-22-000129
Filed
Sep 21, 2022
Trade date
Sep 19-20, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 16 non-derivative transactions and 8 derivative transactions. Open-market sales total $14.2M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mehrotra ParthCIK 0001858398Officer (President and COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 19, 2022Common Stock, par value $0.01 per shareMOption exerciseAcquired+35,073$2.00+$70,146132,464Direct
Sep 19, 2022Common Stock, par value $0.01 per shareMOption exerciseAcquired+103,474$2.00+$206,948235,938Direct
Sep 19, 2022Common Stock, par value $0.01 per shareSSaleDisposed−75,617$37.60F2−$2,843,199.2160,321Direct
Sep 19, 2022Common Stock, par value $0.01 per shareSSaleDisposed−60,700$38.10F3−$2,312,67099,621Direct
Sep 19, 2022Common Stock, par value $0.01 per shareSSaleDisposed−2,230$38.94F4−$86,836.297,391Direct
Sep 19, 2022Common Stock, par value $0.01 per shareMOption exerciseAcquired+27,697$2.00+$55,39427,697Indirect
Sep 19, 2022Common Stock, par value $0.01 per shareMOption exerciseAcquired+80,005$2.00+$160,010107,702Indirect
Sep 19, 2022Common Stock, par value $0.01 per shareSSaleDisposed−37,442$37.48F5−$1,403,326.1670,260Indirect
Sep 19, 2022Common Stock, par value $0.01 per shareSSaleDisposed−67,720$37.96F6−$2,570,651.22,540Indirect
Sep 19, 2022Common Stock, par value $0.01 per shareSSaleDisposed−2,540$38.89F7−$98,780.60Indirect
Sep 20, 2022Common Stock, par value $0.01 per shareMOption exerciseAcquired+30,156$2.00+$60,312127,547Direct
Sep 20, 2022Common Stock, par value $0.01 per shareMOption exerciseAcquired+35,855$2.00+$71,710163,402Direct
Sep 20, 2022Common Stock, $0.01 par value per shareSSaleDisposed−66,011$37.30F8−$2,462,210.397,391Direct
Sep 20, 2022Common Stock, par value $0.01 per shareMOption exerciseAcquired+39,494$2.00+$78,98839,494Indirect
Sep 20, 2022Common Stock, par value $0.01 per shareMOption exerciseAcquired+24,211$2.00+$48,42263,705Indirect
Sep 20, 2022Common Stock, par value $0.01 per shareSSaleDisposed−63,705$37.31F9−$2,376,833.550Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 19, 2022Common StockMOption exerciseDisposed−35,073$0.00$01,310,619Direct
Sep 19, 2022Common StockMOption exerciseDisposed−103,474$0.00$0308,432Direct
Sep 19, 2022Common StockMOption exerciseDisposed−27,697$0.00$0311,500Indirect
Sep 19, 2022Common StockMOption exerciseDisposed−80,005$0.00$024,211Indirect
Sep 20, 2022Common StockMOption exerciseDisposed−30,156$0.00$01,280,463Direct
Sep 20, 2022Common StockMOption exerciseDisposed−35,855$0.00$0272,577Direct
Sep 20, 2022Common StockMOption exerciseDisposed−39,494$0.00$0272,006Indirect
Sep 20, 2022Common StockMOption exerciseDisposed−24,211$0.00$00Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.82 to $37.81 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.82 to $38.79 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.82 to $39.12 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.78 to $37.77 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.78 to $38.77 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.79 to $39.05 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.89 to $37.79 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.90 to $37.79 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)